Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c999da6ceacdb7989620516d686b29da |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 |
filingDate |
2018-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7df46da692de60b4250770efb5f97ae1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cc577b1210210c4857330afa278c02b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f702b68a137da150f4f6ef05f8b3d253 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14656ca837f7c25f9ea36aabe0c6be45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d747bf0a1997a0bfec42682ca4c69703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25d2e2850684272ccded2f9c6c2a087a |
publicationDate |
2020-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-111093626-A |
titleOfInvention |
Stable liquid composition of pemetrexed |
abstract |
The present invention relates to stable liquid pharmaceutical compositions for parenteral administration of pemetrexed. The present invention provides a composition comprising pemetrexed acid, an organic amine and a cyclodextrin. The composition may further comprise an inert gas. The composition can be used as an infusion solution of pemetrexed acid or a liquid concentrate formulation to be diluted prior to administration to a patient. The present invention further relates to a method of preparing the composition and the use of the composition of the present invention in the treatment of malignant pleural mesothelioma and non-small cell lung cancer. |
priorityDate |
2017-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |